GAIN THERAPEUTICS, INC Proceeds from Long-Term Debt Issued
GAIN THERAPEUTICS, INC (GANX) reported Proceeds from Long-Term Debt Issued of $738.28 thousand for the 12-month period ending 2020-12-31, per its 10-K filed 2022-03-25.
Discontinued › Cash Flow › Financing Activities
us-gaap:ProceedsFromIssuanceOfLongTermDebt · last filed 2022-03-25
- GAIN THERAPEUTICS, INC proceeds from issuance of long-term debt for the quarter ending 2020-12-31 was $30.40K.
- GAIN THERAPEUTICS, INC proceeds from issuance of long-term debt for the quarter ending 2020-09-30 was $423.29K.
- GAIN THERAPEUTICS, INC proceeds from issuance of long-term debt for the quarter ending 2020-06-30 was $0.00.
- GAIN THERAPEUTICS, INC proceeds from issuance of long-term debt for the quarter ending 2020-03-31 was $284.60K.
- GAIN THERAPEUTICS, INC proceeds from issuance of long-term debt for fiscal 2020 was $738.28K.
| Period end | Proceeds from Issuance of Long-term Debt 3 month | Proceeds from Issuance of Long-term Debt 6 month | Proceeds from Issuance of Long-term Debt 9 month | Proceeds from Issuance of Long-term Debt 12 month |
|---|---|---|---|---|
| 2020-12-31 | $30.40K derived: 10-K 12 month − 10-Q 9 month · filed 2022-03-25 | $453.68K derived: sum of 2 quarters · filed 2022-03-25 | $453.68K derived: sum of 3 quarters · filed 2022-03-25 | $738.28K 10-K · filed 2022-03-25 |
| 2020-09-30 | $423.29K derived: 10-Q 9 month − 10-Q 6 month · filed 2021-11-12 | $423.29K derived: sum of 2 quarters · filed 2021-11-12 | $707.89K 10-Q · filed 2021-11-12 | |
| 2020-06-30 | $0.00 derived: 10-Q 6 month − 10-Q 3 month · filed 2021-08-12 | $284.60K 10-Q · filed 2021-08-12 | ||
| 2020-03-31 | $284.60K 10-Q · filed 2021-05-10 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Lifevantage Corp (LFVN) | United States | $0.078B | 15.40 |
| Adicet Bio, Inc. (ACET) | United States | $0.078B | -0.81 |
| Valion Bio, Inc. (VBIO) | United States | $0.077B | |
| MAIA Biotechnology, Inc. (MAIA) | United States | $0.077B | -2.30 |
| iBio, Inc. (IBIO) | United States | $0.077B | -2.94 |
| Telomir Pharmaceuticals, Inc. (TELO) | United States | $0.084B | |
| Lexaria Bioscience Corp. (LEXX) | $0.084B | -1.92 | |
| Verrica Pharmaceuticals Inc. (VRCA) | United States | $0.076B | -3.39 |
| OS Therapies Inc (OSTX) | United States | $0.076B | -2.17 |
| NEONC TECHNOLOGIES HOLDINGS, INC. (NTHI) | United States | $0.086B |